
The Hidden Threat After Surgery: RGCC Detection of Circulating Tumor Cell Micro Residue
Surgery is often the first step in the treatment of cancer patients. However, even when the surgery successfully removes the tumor, the risk of cancer recurrence still exists. Traditional imaging and histological tests can only detect significant changes when the tumor has grown or metastasized, making it impossible to capture the tiny remnants of cancer cells in time. This means that many patients may appear to be cancer-free after surgery, but potential cancer cells remain, leading to disease recurrence.








